The complex nature of timing the release of results and specifically why Covid result is not yet available could always be because BIT225 has a broad spectrum of applications.
We have been advised of HIV ( art supplementary),Covid (mouse model so far), further Corona viruses, Zika etc and as a General Antiviral.
Has there yet been an antiviral or any other drug type with this potential?
Then how do they value the package?
It seems obvious that a single BP buyer would be easiest.
Is there any fear of missing out factor?
The MM comment has some reason for validity plus the “No CR” one.
Complete headline results for Commercial Deal, when?, page-286
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.001(5.26%) |
Mkt cap ! $18.04M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 2.0¢ | 1.9¢ | $6.191K | 315.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 963297 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 1734532 | 5 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| BIT (ASX) Chart |